Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Rippee
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3k3a-Apc, a Recombinant Variant of Human Activated Protein C, in Combination With Tissue Plasminogen Activ
Annals of Neurology
Neurology